Table 2.
Coefficient | SE | t value | p-value | ||
---|---|---|---|---|---|
Travel distance | Intercept | 8.374 | 0.117 | 71.413 | <0.001 * |
BalbC | 0.068 | 0.154 | 0.444 | 0.658 | |
C3H | −1.176 | 0.154 | −7.64 | <0.001 * | |
DBA2 | −0.004 | 0.153 | −0.025 | 0.98 | |
Trial | 0.218 | 0.153 | 1.429 | 0.157 | |
DBA2 * Trial | −0.559 | 0.216 | −2.585 | 0.012 * | |
Time in center | Intercept | 3.656 | 0.334 | 10.958 | <0.001 * |
BalbC | 0.343 | 0.5 | 0.686 | 0.495 | |
C3H | 1.844 | 0.472 | 3.908 | <0.001 * | |
DBA2 | −0.527 | 0.472 | −1.116 | 0.268 | |
Trial | −0.053 | 0.472 | −0.115 | 0.911 | |
Entries in center | Intercept | 2.998 | 0.225 | 11.755 | <0.001 * |
Balbc | −1.764 | 0.389 | −4.53 | <0.001 * | |
C3H | −1.719 | 0.409 | −4.206 | <0.001 * | |
DBA2 | −0.606 | 0.353 | −1.718 | 0.091 | |
Trial | 0.17 | 0.353 | 0.483 | 0.631 | |
DBA2 * Trial | −1.104 | 0.506 | −2.182 | 0.033* | |
Distance in center | Intercept | 6.603 | 0.266 | 22.776 | <0.001 * |
BalbC | −0.497 | 0.399 | −1.246 | 0.217 | |
C3H | −0.277 | 0.376 | −0.736 | 0.464 | |
DBA2 | −0.656 | 0.376 | −1.742 | 0.086 | |
Trial | 0.202 | 0.376 | 0.535 | 0.594 | |
Immobility time | Intercept | 4.699 | 0.297 | 15.842 | <0.001 * |
BalbC | −1.134 | 0.419 | 0.136 | 0.892 | |
C3H | −1.134 | 0.419 | −2.704 | 0.009* | |
DBA2 | −2.118 | 0.419 | −5.049 | <0.001 * | |
Trial | −0.335 | 0.419 | −0.798 | 0.428 | |
Latency to immobility | Intercept | 2.876 | 0.341 | 8.427 | <0.001 * |
BalbC | 1.674 | 0.458 | 0.315 | 0.754 | |
C3H | 0.13 | 0.469 | 0.278 | 0.782 | |
DBA2 | 1.674 | 0.458 | 3.656 | <0.001 * | |
Trial | 1.668 | 0.458 | 3.642 | <0.001 * | |
Social interaction time | Intercept | 5.321 | 0.189 | 28.135 | <0.001 * |
BalbC | 0.05 | 0.267 | 0.188 | 0.851 | |
C3H | −0.689 | 0.267 | −2.578 | 0.012 * | |
DBA2 | −0.926 | 0.394 | −2.353 | 0.022 * | |
Trial | −0.438 | 0.267 | −1.637 | 0.107 | |
DBA2 * Trial | −1.997 | 0.485 | −4.116 | <0.001 * | |
Number of social bouts | Intercept | 3.364 | 0.174 | 19.328 | <0.001 * |
BalbC | −0.268 | 0.246 | −1.09 | 0.28 | |
C3H | −0.921 | 0.246 | −3.744 | <0.001 * | |
DBA2 | −1.204 | 0.362 | −3.324 | <0.001 * | |
Trial | −0.339 | 0.246 | −1.376 | 0.174 | |
DBA2 * Trial | −0.905 | 0.447 | −2.206 | 0.047 * | |
Latency to approach | Intercept | 2.614 | 0.612 | 4.27 | <0.001 * |
BalbC | −1.537 | 0.741 | −2.075 | 0.043 * | |
C3H | 0.837 | 0.587 | 1.425 | 0.16 | |
DBA2 | 3.692 | 0.58 | 6.364 | <0.001 * | |
Trial | 0.285 | 0.625 | 0.455 | 0.651 | |
Self-grooming | Intercept | 2.199 | 0.914 | 2.405 | 0.020 * |
BalbC | 1.143 | 0.964 | 1.186 | 0.242 | |
C3H | 1.834 | 0.964 | 1.903 | 0.063 | |
DBA2 | 0.937 | 0.964 | 0.972 | 0.336 | |
Trial | 0.441 | 1.056 | 0.418 | 0.678 |
The stage was designated as a random effect. BalbC, C3H and DBA2 were compared to B6, which was assigned as the baseline. For interaction between strain and trial, only interactions with significance were listed. Bold indicates p-value <0.05.